Does Nicotine Protect Against Covid? This is the very serious hypothesis of a Pitié-Salpêtrière team and a world renowned neurobiologist. It should soon be the subject of a clinical study: nicotinic patches will be administered to patients and caregivers to measure the effects.
Nicotine, a preventive and curative remedy against Covid, is therefore the hypothesis defended by an internal medicine team from the Pitié Salpétrière hospital, and a world-renowned neurobiologist, member of the Academy of Sciences, Jean-Pierre Changeux.
A new study in cell cultures suggests that ivermectin, an existing antiparasitic drug, is able to eliminate SARS-CoV-2 within 48 hours. However, whether this approach is safe and effective in human beings remains to be seen.
As the race toward an efficient treatment for coronavirus disease 19 (COVID-19) continues, researchers are experimenting with new and old drugs alike.
A study paper recently published in the journal Antiviral Research indicates that investigators from the Victorian Infectious Diseases Reference Laboratory (VIDRL) and Monash University, both in Melbourne, Australia, may have found a viable treatment: an existing antiparasitic drug called ivermectin.
A mix of legacy drug makers and small startups have stepped forward with plans to develop vaccines or treatments that target the infection caused by the novel coronavirus.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first detected in December in Wuhan, China, has sickened more than 1,150,000 people worldwide and killed at least 64,500. There are no approved vaccines or therapies for the disease although the use of hydroxychloroquine sulfate and chloroquine phosphate to treat COVID-19 patients is authorised.
On Saturday the Food and Drug Administration approved the use of two antimalarial drugs, hydroxychloroquine and a related medication, chloroquine, for emergency use to treat COVID-19. The drugs were touted by President Trump as a “game changer” for COVID-19.
However, a study just published in a French medical journal provides new evidence that hydroxychloroquine does not appear to help the immune system clear the coronavirus from the body. The study comes on the heels of two others - one in France and one in China - that reported some benefits in the combination of hydroxychloroquine and azithromycin for COVID-19 patients who didn’t have severe symptoms of the virus.